Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Syros Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- −10 vs. Q3 2021
- Shares held
- 51.2M
- +1.05M (+2.1%) vs. Q3 2021
- Total value
- $166.0M
- −$57.1M (−25.6%) vs. Q3 2021
- New holders
- 12
- 31 more added
- Sold out
- 22
- 32 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $12.4K |
| Q4 2024 | 44 | $1.20M |
| Q3 2024 | 65 | $40.8M |
| Q2 2024 | 70 | $105.2M |
| Q1 2024 | 75 | $111.9M |
| Q4 2023 | 58 | $146.8M |
| Q3 2023 | 48 | $47.9M |
| Q2 2023 | 53 | $33.5M |
| Q1 2023 | 59 | $27.5M |
| Q4 2022 | 57 | $37.9M |
| Q3 2022 | 53 | $59.9M |
| Q2 2022 | 69 | $34.2M |
| Q1 2022 | 94 | $53.1M |
| Q4 2021 | 90 | $166.0M |
| Q3 2021 | 100 | $223.1M |
| Q2 2021 | 100 | $276.0M |
| Q1 2021 | 106 | $475.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Trexquant Investment LP | 0 | $0 | 0.00% | −30,162−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −21,697−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,940−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −16,415−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −12,690−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −12,239−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,415−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −514−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |